Skip to main content
Premium Trial:

Request an Annual Quote

Personalis Taps Berry Genomics to Facilitate Expansion in China

NEW YORK – Personalis said on Wednesday that it is partnering with Berry Genomics to facilitate its expansion into China.

Personalis said that it plans to form a wholly owned subsidiary in Shanghai, including a laboratory for local customers to use its ImmunoID NeXT platform, a commercial team to support local customers, and general and administrative functions.

Under the terms of the agreement, Berry Genomics will provide Personalis with certain services and local support.

"Having achieved a high degree of scale in our Menlo Park, California operation, we are poised to expand globally, and entering into a partnership with a company that has the track record and capabilities of Berry Genomics will help us accelerate the ramp-up of our operation," Personalis CEO John West said in a statement. "Both companies have benefited from experience founded in the origin of next-generation sequencing, and together we will take it even further."

The ImmunoID NeXT platform leverages deep sequencing to enable researchers studying immune- and precision oncology to comprehensively analyze a tumor and its microenvironment from a single sample across the entire approximately 20,000-gene footprint.

Earlier this year Personalis launched a dedicated pharmaceutical services program to expand beyond its translational and clinical cancer research customer base.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.